Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.44 |
| ▸ | ELANE | P08246 | 4/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10440811 | 0.88 | HPGD (0.44) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL1829849 | 0.80 | HPGD (0.58) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL6735667 | 0.78 | HPGD (0.61) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL18747584 | 0.75 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL14372105 | 0.75 | ALDH1A1 (0.46) | ALDH1A1MAPTRAB9ALMNA | |
| SCHEMBL329718 | 0.74 | HPGD (0.63) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL20650991 | 0.73 | ALDH1A1 (0.48) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL13813888 | 0.73 | LMNA (0.48) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL23355253 | 0.73 | ELANE (0.55) | HPGDALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL931848 | 0.72 | MEN1 (0.42) | HPGDALDH1A1MAPTNPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729532-B2 | Light-absorbing material and photoelectric conversion element | PANASONIC CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729532-B2 | Light-absorbing material and photoelectric conversion element | PANASONIC CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20120181516-A1 | LIGHT-ABSORBING MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT | PANASONIC ELECTRIC WORKS CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20120181516-A1 | LIGHT-ABSORBING MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT | PANASONIC ELECTRIC WORKS CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| EP-2433989-A1 | LIGHT-ABSORBING MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT | Panasonic Corporation (JP) | 2012-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120181516-A1 | LIGHT-ABSORBING MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT | PPOX, CRY1, CYBA | HPGD 567/4885ALDH1A1 110/4885MAPT 3623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.